Low-Dose Naltrexone for Treatment of Multiple Sclerosis: Clinical Trials are Needed

National Multiple Sclerosis Society. Epidemiology. www.nationalmssociety.org/site/PageServer?pagename=HOM_LIB_sourcebook_epidemiology (accessed 2007 Jun 28).

Agrawal YP . Low dose naltrexone therapy in multiple sclerosis. Med Hypotheses 2005;64:721–4.

Agrawal YP . Possible importance of antibiotics and naltrexone in neurodegenerative disease. Eur J Neurol 2006;13(9):e7.

Good P . Low-dose naltrexone for multiple sclerosis and autism: does its benefit reveal a common cause (letter)? Med Hypotheses 2006;67:671–2.

The National Multiple Sclerosis Society. Low dose naltrexone update. www.nationalmssociety.org/clinup-naltrexone.asp (accessed 2006 Oct 23).

Low dose naltrexone. www.lowdosenaltrexone.org (accessed 2006 Oct 25).

The National Multiple Sclerosis Society. Low dose naltrexone update. www.nationalmssociety.org/site/PageServer?pagename=HOM_LIVE_clinup_naltrexone (accessed 2007 May 15).

UCSF Multiple Sclerosis Center. Low dose naltrexone. http://mscenter.ucsf.edu/research.htm (accessed 2007 May 14).